Longer term post-hospital morbidity and mortality following admission with COVID-19: a systematic review and meta-analysis publications.ersnet.org/content/erjor/… Joe Newman Luke Flower Mark Toshner Charlotte Summers

Great to see this research published online today, led by our fantastic collaborators in Sheffield Frankie et al 🏆 - evaluating Patient Reported Outcome Measures #PROMs in #PulmonaryHypertension

ERJOR: A walk test of 3 min still detects most desaturation events with equivalent prognostic value. Shorter walk tests could be used clinically, which would be a more efficient and patient-centred approach and also help the move towards remote monitoring. bit.ly/43rebnv

My recent publication showing the usefulness of 3 min walk in ILD

The airport signage isn’t letting me leave my research behind on holiday… Speaking of which, check out our new paper on an alternative to the #6MinuteWalkTest in #ILD to detect ambulatory hypoxia: bit.ly/43rebnv 🚶🏻‍♀️ 🫁 Lucy Robertson Dr Karl Sylvester Royal Papworth Hospital NHS FT 💙

Pleased as punch for my student Vidisha. At our local NIHR day she got best poster award for research that involves participants and patients-putting them front and centre!

Great news! Key findings just published in the ERJ Open Research from our Pulmonary Hypertension Global Patient Survey #PHGPS adult cohort of 3,329 patients highlight the achievements, shortcomings & regional disparities of #PH clinical care & research globally. Findings in the

Immunomodulatory therapies in community-acquired pneumonia: a protocol for a systematic review and network meta-analysis BMJ_Open Luke Flower bmjopen.bmj.com/content/15/7/e…

📢 Good news! 📢Our #PHGPS, the largest global survey exploring the perspectives of #PulmonaryHypertension patients, has identified 10 key global priorities for improving #PulmonaryHypertension care in adult patients. These 10 calls to action aim to enhance equitable access to

📢Big news for the PH community! Findings from the global PH GPS adult survey (3,300+ patients, 90 countries) are now published. PHAEUROPE’s Eva Otter & Gery Fischer are among co-authors. ⤵️ tinyurl.com/yjurrmhn

The 10 “Calls to Action” aim to improve diagnosis, care, and support for all with PH. Explore insights & priorities here: doi.org/10.1183/231205… & doi.org/10.1002/pul2.7… #PHGPS #PulmonaryHypertension #PatientVoice #PHAEurope

🌍Did you know? ...in 2023/4 over 3000 patients or their loved ones responded to the Pulmonary Hypertension Global Patient Survey, providing a unique insight to their lived experience with the disease. Read the full #PHGPS paper to explore the key findings 👉

📢 From Patient Voices to Action: Understanding the PH Global Survey - A Webinar for Patients and Carers on PHGPS European Findings 📅 Friday, 29 August | 🕚 11:00 BST | 💻 Online via Zoom We’re excited to invite you to a free, patient-focused webinar that unpacks key findings

📣 PHAEUROPE invites you to a free, patient-focused webinar unpacking key findings from the Pulmonary Hypertension Global Patient Survey (PHGPS), with a focus on European adult data. Hall Skaara and Dr. Frances Varian will discuss⤵️

🎥 From Patient Voices to Action: Understanding the PH Global Survey - Webinar Recording Now Available On-Demand! Did you miss our live session on the Pulmonary Hypertension Global Patient Survey (PHGPS)? You can now catch up and watch the full discussion anytime. In this

A brilliant few days at #ERS in Amsterdam catching up with friends & colleagues from Cambridge & clinicians/scientists from around the world on all things #respiratory from COVID-19 to pulmonary hypertension research. 🫁 A few highlights from across the conference & city below.

Published today!

❓ Did you know? Only 21% of patients reported ever completing a Patient Reported Outcome Measure (PROM) — even though clinical guidelines recommend their regular use to understand how PH affects quality of life. These tools can help ensure that patient voices are heard and